Global strategies for cervical cancer prevention and screening

Minerva ginecologica
Sharmila Pimple, Gauravi Mishra

Abstract

Cervical cancer is highly preventable and can be easily treated if detected at early stages. However there is disproportionate high burden of cervical cancer incidence and mortality in low-middle income (LMIC) country settings that lack organised screening and prevention programs. Robust evidence for prevention and screening of cervical cancer is currently available. However there are barriers for country specific adoption and implementation. These pose unique challenges such as organising prevention and screening services delivery through the current health infrastructure, access to screening facilities, follow up management and adequate linkages for confirmatory diagnosis and subsequent treatment. Overall cervical cancer screening rates and cancer screening among women still remains suboptimal in many LMIC's. Considering the complexities involved in organisation, service uptake and delivery of population based cervical cancer prevention and screening programs, this article aims to provide evidence based appropriate, affordable and effective standardised cervical cancer prevention and screening guidelines that are operationally feasible to help adopt best practices for uniform adaptation and implementation leveraging with the ...Continue Reading

References

Jul 23, 1994·BMJ : British Medical Journal·J Austoker
Jun 19, 1993·International Journal of Cancer. Journal International Du Cancer·K Sigurdsson
Feb 1, 1997·Australian and New Zealand Journal of Public Health·D Mak, J A Straton
Nov 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Linos, E Riza
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L MadlenskyF D Ashbury
Jun 2, 2004·International Journal of Cancer. Journal International Du Cancer·Rengaswamy SankaranarayananUNKNOWN IARC Multicentre Study Group on Cervical Cancer Early Detection
Aug 19, 2004·Cancer·Anne MilesJane Wardle
Nov 18, 2005·The New England Journal of Medicine·Sue J GoldieUNKNOWN Alliance for Cervical Cancer Prevention Cost Working Group
Mar 30, 2006·Journal of Medical Screening·Elsebeth LyngePaul Poll
Mar 28, 2008·Journal of the National Cancer Institute·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer Screening Working Group
Apr 12, 2008·International Journal of Cancer. Journal International Du Cancer·Marc ArbynParthasarathy Basu
Apr 3, 2009·The New England Journal of Medicine·Rengaswamy SankaranarayananKetayun A Dinshaw
Jun 16, 2009·Biologicals : Journal of the International Association of Biological Standardization· Who
Dec 17, 2009·The Lancet Oncology·Rengaswamy SankaranarayananNasser Al-Hamdan
Sep 13, 2011·Journal of the National Cancer Institute·Aimée R KreimerUNKNOWN CVT Vaccine Group
Nov 16, 2011·Bulletin of the World Health Organization·D Scott LaMontagneAisha O Jumaan
Mar 6, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Thomas C Wright, Louise Kuhn
May 9, 2012·Pediatrics·Allison KempeL Miriam Dickinson
Mar 26, 2013·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Brenda CassidyElizabeth A Schlenk
Nov 28, 2013·Vaccine·F Xavier BoschUNKNOWN Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5,
Nov 26, 2013·International Journal of Cancer. Journal International Du Cancer·Richard MuwongeRengaswamy Sankaranarayanan
Jan 15, 2014·Vaccine·Alinea S NoronhaEileen F Dunne
Jan 22, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G DijkstraC J L M Meijer
Feb 25, 2014·Journal of the National Cancer Institute·Surendra S ShastriRajendra A Badwe
Feb 26, 2014·Journal of Epidemiology and Community Health·Angela M SpencerArpana Verma
Oct 6, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jane H WilliamsLucie Rychetnik
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 14, 2015·The Lancet Oncology·Aimée R KreimerUNKNOWN GSK Vaccines Clinical Study Support Group
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Feb 4, 2016·Human Vaccines & Immunotherapeutics·Elizabeth A SmulianShannon Stokley

❮ Previous
Next ❯

Citations

Jan 1, 2020·The Kaohsiung Journal of Medical Sciences·Qing-Lan HuBei Li
Jul 28, 2020·Journal of Experimental & Clinical Cancer Research : CR·Shuzhen TianXi Chen
Mar 18, 2021·The Kaohsiung Journal of Medical Sciences·Tie-Fang SongXian-Chao Kong
Jul 4, 2021·Public Health Nursing·Claudia Fernandes RodriguesRaphael Mendonça Guimarães

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Obstetrics & Gynecology
Sharmila PimpleSurendra Shastri
Annals of Burns and Fire Disasters
M A R Stokes, W D Johnson
© 2022 Meta ULC. All rights reserved